» Articles » PMID: 30868574

Performance of Individual and Joint Risk Stratification by an Environmental Risk Score and a Genetic Risk Score in a Colorectal Cancer Screening Setting

Overview
Journal Int J Cancer
Specialty Oncology
Date 2019 Mar 15
PMID 30868574
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Early detection of colorectal neoplasms can reduce the disease burden of colorectal cancer by timely intervention of individuals at high risk. Our aim was to evaluate a joint environmental-genetic risk score as a risk stratification tool for early detection of advanced colorectal neoplasm (ACRN). Known environmental risk factors and high-risk genetic loci were summarized into risk scores for ACRN in 1014 eligible participants of a screening study. The performances of single and joint environmental-genetic scores were evaluated with estimates and 95% confidence intervals (CI) of the absolute risk, relative risk and predictive ability using the area under the curve (AUC). Individuals with higher environmental risk scores showed increasing ACRN risk, with 3.1-fold for intermediate risk and 4.8-fold for very high risk, compared to the very low environmental risk group. Similarly, individuals with higher genetic risk scores showed increasing ACRN risk, with 2.2-fold for intermediate risk and 3.5-fold for very high risk, compared to the lowest genetic risk group. Moreover, the joint environmental-genetic score improved the ACRN risk stratification and showed higher predictive values (AUC = 0.64; 95%CI = 0.60-0.67) with substantial difference (p = 0.0002) compared to the single environmental score (0.58; 0.55-0.62). The integration of environmental and genetic factors looks promising for improving targeting individuals at high-risk of colorectal neoplasm. Applications in practical screening programs require optimization with additional genetic and other biomarkers involved in colorectal carcinogenesis.

Citing Articles

Systematic review: risk prediction models for metachronous advanced colorectal neoplasia after polypectomy.

Kang J, Levine E, Fleet A, Padilla M, Lee J, Harrison H J Gastroenterol Hepatol. 2024; 39(12):2533-2544.

PMID: 39080790 PMC: 11660205. DOI: 10.1111/jgh.16682.


Colorectal Cancer Risk Assessment and Precision Approaches to Screening: Brave New World or Worlds Apart?.

Kastrinos F, Kupfer S, Gupta S Gastroenterology. 2023; 164(5):812-827.

PMID: 36841490 PMC: 10370261. DOI: 10.1053/j.gastro.2023.02.021.


Serum protein profiling of lung, pancreatic, and colorectal cancers reveals alcohol consumption-mediated disruptions in early-stage cancer detection.

Lee H, Kim S, Kim D, Park Y, Hwang J, Cho S Heliyon. 2023; 8(12):e12359.

PMID: 36590537 PMC: 9794896. DOI: 10.1016/j.heliyon.2022.e12359.


Validation of a multi-ancestry polygenic risk score and age-specific risks of prostate cancer: A meta-analysis within diverse populations.

Chen F, Darst B, Madduri R, Rodriguez A, Sheng X, Rentsch C Elife. 2022; 11.

PMID: 35801699 PMC: 9322982. DOI: 10.7554/eLife.78304.


Evaluating the Potential of Polygenic Risk Score to Improve Colorectal Cancer Screening.

Arnau-Collell C, Diez-Villanueva A, Bellosillo B, Auge J, Munoz J, Guino E Cancer Epidemiol Biomarkers Prev. 2022; 31(7):1305-1312.

PMID: 35511747 PMC: 9355543. DOI: 10.1158/1055-9965.EPI-22-0042.